Showing results (61-70 of 382) with videos related to
Sort By:
Pageof 39
The Lancet. Neurology|July 10, 2003
Genes and parkinsonismJohn Hardy, Mark R Cookson, Andrew SingletonBiochemical Society Transactions|March 7, 2019
LRRK2 links genetic and sporadic Parkinson's diseaseJillian H Kluss, Adamantios Mamais, Mark R CooksonMolecular Neurodegeneration|April 7, 2019
Glial phagocytic clearance in Parkinson's diseaseMarie-Eve Tremblay, Mark R Cookson, Laura CivieroBMC Medicine|February 25, 2012
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?Iakov N Rudenko, Ruth Chia, Mark R CooksonJournal of Neurochemistry|November 1, 2016
The impact of fraudulent and irreproducible data to the translational research crisis - solutions and implementationJörg B Schulz, Mark R Cookson, Laura HausmannRNA Biology|December 17, 2015
ADAR2 affects mRNA coding sequence edits with only modest effects on gene expression or splicing in vivoAllissa A Dillman, Mark R Cookson, Dagmar GalterThe Journal of Physiology|May 25, 2019
Leucine rich repeat kinase 2: a paradigm for pleiotropyPatrick A LewisJournal of Parkinson'S Disease|August 14, 2013
James Parkinson: the man behind the shaking palsyPatrick A LewisJournal of Visualized Experiments : Jove|February 4, 2012
Assaying the kinase activity of LRRK2 in vitroPatrick A LewisEssays in Biochemistry|December 13, 2021
Vesicular dysfunction and pathways to neurodegenerationPatrick A LewisPageof 39